Pure Global
NCT06362200

The Validation and Biological Index Studies on the Improved Social Function of ASD by 40 Hz tACS

The Validation and Biological Index Studies on the Improved Social Function of Autism Spectrum Disorder by 40 Hz Transcranial Alternating Current Stimulation
Central South University·ClinicalTrials.gov·device·Device trialNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Autism Spectrum Disorder
Drug/Device/Intervention
40 Hz tACS intervention
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Central South University
Timeline & enrollment
Phase
N/A
Start date
Apr 15, 2024
End date
Dec 31, 2028
Enrollment
60 participants
Primary outcome

Autism assessment assessment index

Summary

In this proposed study, tACS will be used to intervene in the autism spectrum disorders of
 children and adolescents, and the efficacy of this intervention method will be evaluated, as
 well as the internal mechanism of adolescents' autism spectrum disorders will be discussed.

ICD-10 classifications
Childhood autismAtypical autismAsperger syndromeNeurotic disorder, unspecifiedMental and behavioural disorders
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06362200
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06362200 through Pure Global AI's free database. This phase not specified trial is sponsored by Central South University and is currently Not yet recruiting. The study focuses on Autism Spectrum Disorder. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.